Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 51 | 2025 | 861 | 8.380 |
Why?
|
| Blood Glucose Self-Monitoring | 33 | 2025 | 124 | 6.220 |
Why?
|
| Blood Glucose | 33 | 2025 | 1121 | 4.450 |
Why?
|
| Insulin Infusion Systems | 24 | 2025 | 66 | 4.420 |
Why?
|
| Hypoglycemia | 16 | 2025 | 183 | 3.910 |
Why?
|
| Hypoglycemic Agents | 29 | 2025 | 482 | 3.130 |
Why?
|
| Insulin | 24 | 2025 | 1168 | 2.670 |
Why?
|
| Diabetic Ketoacidosis | 6 | 2025 | 166 | 1.370 |
Why?
|
| Hyperglycemia | 6 | 2022 | 235 | 1.000 |
Why?
|
| Automobile Driving | 1 | 2025 | 34 | 0.880 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 155 | 0.720 |
Why?
|
| Wearable Electronic Devices | 2 | 2022 | 107 | 0.680 |
Why?
|
| Adolescent | 32 | 2025 | 20544 | 0.650 |
Why?
|
| Child | 38 | 2025 | 25765 | 0.640 |
Why?
|
| Registries | 5 | 2021 | 1579 | 0.580 |
Why?
|
| Monitoring, Ambulatory | 4 | 2020 | 56 | 0.520 |
Why?
|
| Child, Preschool | 21 | 2025 | 14736 | 0.490 |
Why?
|
| Humans | 60 | 2025 | 132013 | 0.480 |
Why?
|
| Young Adult | 18 | 2025 | 9952 | 0.480 |
Why?
|
| Adipose Tissue | 2 | 2016 | 510 | 0.470 |
Why?
|
| Male | 38 | 2025 | 64914 | 0.420 |
Why?
|
| Female | 40 | 2025 | 70643 | 0.420 |
Why?
|
| Parents | 6 | 2020 | 1079 | 0.410 |
Why?
|
| Self-Management | 2 | 2025 | 104 | 0.400 |
Why?
|
| Adrenarche | 1 | 2013 | 11 | 0.390 |
Why?
|
| Puberty, Precocious | 1 | 2013 | 29 | 0.390 |
Why?
|
| Bone Development | 1 | 2013 | 55 | 0.390 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2013 | 34 | 0.390 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 377 | 0.380 |
Why?
|
| Telemedicine | 2 | 2021 | 494 | 0.370 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 923 | 0.320 |
Why?
|
| Adult | 22 | 2024 | 31563 | 0.320 |
Why?
|
| Curriculum | 2 | 2020 | 767 | 0.290 |
Why?
|
| Caregivers | 2 | 2024 | 588 | 0.280 |
Why?
|
| Hypopituitarism | 1 | 2008 | 18 | 0.280 |
Why?
|
| Pilot Projects | 3 | 2025 | 1441 | 0.270 |
Why?
|
| Health Status Disparities | 2 | 2021 | 253 | 0.270 |
Why?
|
| Camping | 3 | 2016 | 14 | 0.260 |
Why?
|
| Cholestasis | 1 | 2008 | 157 | 0.240 |
Why?
|
| Prospective Studies | 6 | 2023 | 6568 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 482 | 0.200 |
Why?
|
| Self Care | 1 | 2025 | 227 | 0.200 |
Why?
|
| Biosensing Techniques | 2 | 2014 | 67 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 80 | 0.200 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3760 | 0.190 |
Why?
|
| Glucose | 3 | 2022 | 870 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2024 | 575 | 0.190 |
Why?
|
| Quality of Life | 4 | 2025 | 2157 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2012 | 1256 | 0.180 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2021 | 18 | 0.180 |
Why?
|
| Off-Label Use | 1 | 2021 | 28 | 0.180 |
Why?
|
| Demography | 1 | 2021 | 241 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1411 | 0.170 |
Why?
|
| Sodium | 1 | 2021 | 295 | 0.160 |
Why?
|
| Technology | 1 | 2020 | 69 | 0.160 |
Why?
|
| Hypertrophy | 2 | 2016 | 101 | 0.150 |
Why?
|
| Diabetic Retinopathy | 1 | 2021 | 168 | 0.150 |
Why?
|
| Feeding and Eating Disorders | 1 | 2019 | 76 | 0.140 |
Why?
|
| Medicare | 1 | 2021 | 447 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2019 | 285 | 0.140 |
Why?
|
| Minority Groups | 1 | 2019 | 249 | 0.140 |
Why?
|
| Pancreas, Artificial | 1 | 2016 | 2 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 325 | 0.130 |
Why?
|
| Clinical Alarms | 1 | 2016 | 9 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 151 | 0.130 |
Why?
|
| United States | 6 | 2024 | 11655 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 699 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2024 | 12987 | 0.120 |
Why?
|
| Consensus | 3 | 2025 | 649 | 0.120 |
Why?
|
| Hormones | 1 | 2016 | 170 | 0.120 |
Why?
|
| Infusion Pumps, Implantable | 3 | 2020 | 38 | 0.120 |
Why?
|
| Fear | 1 | 2017 | 205 | 0.120 |
Why?
|
| Hospitalization | 1 | 2024 | 1897 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2018 | 241 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 485 | 0.110 |
Why?
|
| Acetaminophen | 1 | 2015 | 97 | 0.110 |
Why?
|
| Cell Phone | 1 | 2013 | 36 | 0.100 |
Why?
|
| Texas | 2 | 2021 | 3627 | 0.100 |
Why?
|
| Calibration | 1 | 2013 | 99 | 0.100 |
Why?
|
| Age Factors | 2 | 2018 | 2911 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 3008 | 0.100 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2013 | 24 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2019 | 5166 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2025 | 3088 | 0.100 |
Why?
|
| Anxiety | 1 | 2019 | 991 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2311 | 0.100 |
Why?
|
| Algorithms | 2 | 2016 | 1718 | 0.090 |
Why?
|
| Body Height | 1 | 2013 | 204 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 742 | 0.090 |
Why?
|
| Infant | 5 | 2025 | 13050 | 0.080 |
Why?
|
| Medical Errors | 1 | 2012 | 161 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2013 | 819 | 0.080 |
Why?
|
| Aged | 4 | 2024 | 21406 | 0.080 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2010 | 23 | 0.080 |
Why?
|
| Time Factors | 2 | 2018 | 6441 | 0.080 |
Why?
|
| Hand Strength | 1 | 2010 | 61 | 0.080 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 82 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 91 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 3402 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 1246 | 0.070 |
Why?
|
| Inpatients | 1 | 2012 | 550 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 54 | 0.070 |
Why?
|
| Growth Hormone | 1 | 2008 | 129 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 899 | 0.070 |
Why?
|
| Body Mass Index | 1 | 2013 | 1697 | 0.060 |
Why?
|
| Risk Factors | 3 | 2025 | 10931 | 0.060 |
Why?
|
| Equipment Failure | 2 | 2016 | 136 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 902 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2019 | 664 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2025 | 45 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2016 | 328 | 0.060 |
Why?
|
| Protective Factors | 1 | 2025 | 90 | 0.060 |
Why?
|
| Pandemics | 2 | 2024 | 1183 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 3993 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2023 | 485 | 0.060 |
Why?
|
| Circadian Rhythm | 2 | 2017 | 317 | 0.050 |
Why?
|
| Pediatrics | 1 | 2012 | 1211 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Middle Aged | 5 | 2024 | 28968 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 64 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 309 | 0.050 |
Why?
|
| Baltimore | 1 | 2021 | 18 | 0.050 |
Why?
|
| Recurrence | 1 | 2025 | 1453 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 213 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1500 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 778 | 0.040 |
Why?
|
| Austria | 1 | 2019 | 20 | 0.040 |
Why?
|
| Psychotherapy | 1 | 2022 | 246 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 59 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 333 | 0.040 |
Why?
|
| Developed Countries | 1 | 2019 | 44 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 549 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8542 | 0.040 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2019 | 29 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 5409 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2020 | 108 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 622 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 398 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 159 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 426 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2019 | 262 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 713 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 329 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 157 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 617 | 0.030 |
Why?
|
| Bionics | 1 | 2016 | 2 | 0.030 |
Why?
|
| Learning | 1 | 2020 | 370 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2022 | 994 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 84 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 606 | 0.030 |
Why?
|
| Machine Learning | 1 | 2020 | 345 | 0.030 |
Why?
|
| Health Planning Guidelines | 1 | 2016 | 34 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17374 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 294 | 0.030 |
Why?
|
| Parenting | 1 | 2019 | 349 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1351 | 0.030 |
Why?
|
| Patient Preference | 1 | 2017 | 141 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 160 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 700 | 0.030 |
Why?
|
| Research | 1 | 2016 | 265 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 63 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 61 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2655 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 274 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2139 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5008 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1339 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 322 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 436 | 0.020 |
Why?
|
| Physical Examination | 1 | 2010 | 165 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 355 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 461 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2010 | 428 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 7105 | 0.010 |
Why?
|